Universe Historical Income Statement
| UPC Stock | USD 1.16 0.22 15.94% |
Historical analysis of Universe Pharmaceuticals income statement accounts such as Tax Provision of 1.6 M, Depreciation And Amortization of 413.1 K, Interest Expense of 153.8 K or Selling General Administrative of 1.8 M can show how well Universe Pharmaceuticals performed in making a profits. Evaluating Universe Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Universe Pharmaceuticals's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Universe Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Universe Pharmaceuticals is a good buy for the upcoming year.
Universe |
About Universe Income Statement Analysis
Universe Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Universe Pharmaceuticals shareholders. The income statement also shows Universe investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Universe Pharmaceuticals Income Statement Chart
Add Fundamental
Tax Provision
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.Total Revenue
Total revenue comprises all receipts Universe Pharmaceuticals generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Universe Pharmaceuticals minus its cost of goods sold. It is profit before Universe Pharmaceuticals operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Universe Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Universe Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universe Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.At present, Universe Pharmaceuticals' Gross Profit is projected to increase significantly based on the last few years of reporting.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 162.4K | 156.8K | 180.3K | 153.8K | Depreciation And Amortization | 533.9K | 508.8K | 457.9K | 413.1K |
Universe Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
Universe Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Universe Pharmaceuticals income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Tax Provision | 2.5M | 2.4M | 752.4K | 2.3M | 2.1M | 1.6M | |
| Net Interest Income | (123.8K) | (101.6K) | (162.4K) | (156.8K) | (141.1K) | (148.2K) | |
| Depreciation And Amortization | 410.1K | 446.9K | 533.9K | 508.8K | 457.9K | 413.1K | |
| Interest Expense | 123.8K | 101.6K | 162.4K | 156.8K | 180.3K | 153.8K | |
| Selling General Administrative | 1.2M | 3.3M | 1.8M | 2.2M | 2.5M | 1.8M | |
| Selling And Marketing Expenses | 1.6M | 3.0M | 19.1M | 6.8M | 7.8M | 6.2M | |
| Total Revenue | 30.7M | 48.0M | 40.1M | 32.3M | 37.2M | 39.0M | |
| Gross Profit | 14.1M | 25.3M | 21.9M | 10.3M | 11.9M | 18.0M | |
| Other Operating Expenses | 20.4M | 34.4M | 47.2M | 35.8M | 41.2M | 32.9M | |
| Operating Income | 10.3M | 13.6M | (7.0M) | (3.5M) | (3.2M) | (3.0M) | |
| Net Income From Continuing Ops | 7.6M | 11.3M | (8.7M) | (6.2M) | (5.5M) | (5.3M) | |
| Ebit | 10.2M | 13.7M | (7.9M) | (3.7M) | (3.4M) | (3.2M) | |
| Research Development | 583.1K | 5.5M | 7.6M | 4.9M | 5.6M | 3.7M | |
| Ebitda | 10.6M | 14.2M | (7.3M) | (3.2M) | (2.9M) | (2.7M) | |
| Cost Of Revenue | 16.6M | 22.7M | 18.3M | 22.0M | 25.3M | 21.0M | |
| Total Operating Expenses | 3.7M | 11.7M | 28.9M | 13.8M | 15.9M | 12.0M | |
| Reconciled Depreciation | 410.1K | 446.9K | 533.9K | 508.8K | 585.1K | 508.0K | |
| Income Before Tax | 10.1M | 13.7M | (8.0M) | (3.8M) | (3.5M) | (3.3M) | |
| Total Other Income Expense Net | (151.3K) | 88.3K | (545.3K) | (322.8K) | (290.5K) | (305.0K) | |
| Net Income Applicable To Common Shares | 7.6M | 7.6M | 11.3M | (8.7M) | (7.9M) | (7.5M) | |
| Net Income | 7.6M | 11.3M | (8.7M) | (6.2M) | (5.5M) | (5.3M) | |
| Income Tax Expense | 2.5M | 2.4M | 752.4K | 2.3M | 2.1M | 1.6M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Universe Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Universe Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Universe Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Universe Pharmaceuticals Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universe Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Universe Pharmaceuticals. If investors know Universe will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Universe Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.82) | Earnings Share (76.35) | Revenue Per Share 7.351 | Quarterly Revenue Growth (0.30) | Return On Assets (0.06) |
The market value of Universe Pharmaceuticals is measured differently than its book value, which is the value of Universe that is recorded on the company's balance sheet. Investors also form their own opinion of Universe Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Universe Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Universe Pharmaceuticals' market value can be influenced by many factors that don't directly affect Universe Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Universe Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Universe Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Universe Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.